Table 1.
miRNAs down-regulated during in vitro CD34+ megakaryocytic differentiation
miRNA | Chromosomal location | t test* | Fold change | Putative targets |
---|---|---|---|---|
hsa-mir-010a† | 17q21 | −9.10 | 50.00 | HOXA1, HOXA3, HOXD10, CRK, FLT1 |
hsa-mir-126† | 9q34 | −2.73 | 8.33 | CRK, EVI2, HOXA9, MAFB, CMAF |
hsa-mir-106† | xq26.2 | −2.63 | 2.86 | TAL1, FLT1, SKI, RUNX1, FOG2, FLI, PDGFRA, CRK |
hsa-mir-010b† | 2q31 | −2.17 | 11.11 | HOXA1, HOXA3, HOXD10, ETS-1, CRK, FLT1 |
hsa-mir-130a† | 11q12 | −2.08 | 4.76 | MAFB, MYB, FOG2, CBFB, PDGFRA, SDFR1, CXCL12 |
hsa-mir-130a-prec† | 11q12 | −2.07 | 7.69 | NA‡ |
hsa-mir-124a | 8q23 | −1.81 | 2.78 | TAL1, SKI, FLT1, FOG2, ETS-1, CBFB, RAF1, MYB |
hsa-mir-032-prec | 9q31 | −1.76 | 3.57 | NA‡ |
hsa-mir-101 | 1p31.3 | −1.75 | 3.33 | TAL1, CXCL12, MEIS1, MEIS2, ETS-1 RUNX1, MYB |
hsa-mir-30c | 6q13 | −1.71 | 2.56 | CBFB, MAFG, HOXA1, SBF1, NCOR2, ERG |
hsa-mir-213† | 1q31.3 | −1.69 | 2.38 | MAX-SATB2 |
hsa-mir-132-prec | 17p13 | −1.67 | 4.17 | NA‡ |
hsa-mir-150† | 19q13.3 | −1.63 | 5.26 | MYB, SDFR1 |
hsa-mir-020 | 13q31 | −1.62 | 2.17 | TAL1, SKI, RUNX-1, FLT1, CRK, FOG2, RARB |
hsa-mir-339 | 7p22 | −1.60 | 3.03 | SKI, ETV6, GATA2, FLT1, RAP1B, JUNB, MEIS2 |
hsa-let-7a | 9q22 | −1.58 | 2.94 | HOXA1, HOXA9, MEIS2, ITGB3, PLDN |
hsa-let-7d | 9q22 | −1.56 | 2.17 | HOXA1, HOXD1, ITGB3, RUNX1, PDGFRA |
hsa-mir-181c | 19p13 | −1.55 | 2.50 | RUNX-1, KIT, HOXA1, MEIS2, ETS-1 ETV6, PDGFRA |
hsa-mir-181b | 1q31.3 | −1.53 | 2.13 | RUNX-1, KIT, ITGA3, HOXA1, MEIS2, ETS-1, SDFR1. |
hsa-mir-017 | 13q31 | −1.38 | 1.82 | TAL1, SKI, FLT1, RUNX1, CRK, FOG1, ETS-1, MEIS1 |
All differentially expressed miRNAs have q value <0.01 (false-positive rate).
*t test P < 0.05.
†These miRNAs were identified by PAM as predictors of a megakaryocytic class with the lowest misclassification error. All, except miR-143, are down-regulated during megakaryocytic differentiation.
‡miRNA precursor sequence that not contain the mature miRNA, therefore no putative target is shown.